Analyst	Recommendation	Action	Price target	Projected	Date
Unknown Analyst Freedom Capital Markets	Buy	Initiated	-	-	08/19/2026
Brian Dobson Clear Street	Buy	Reiterated	$170.00	+72.4%	08/18/2026
John Todaro Needham	Buy	Maintained	$138.00	+40%	08/14/2026
Stephen Byrd Morgan Stanley	Buy	Reiterated	$273.00	+176.9%	08/06/2026
Allen Klee Maxim Group	Buy	Reiterated	$170.00	+72.4%	08/05/2026
Gregory Lewis BTIG	Buy	Maintained	$150.00	+52.1%	08/06/2026
Patrick Moley Piper Sandler	Buy	Reiterated	$143.00	+45%	08/06/2026
Chris Brendler Rosenblatt Securities	Buy	Reiterated	$124.00	+25.8%	08/05/2026
Michael Grondahl Northland Securities	Buy	Maintained	$120.00	+21.7%	08/05/2026
Joseph Vafi Canaccord Genuity	Buy	Maintained	$130.00	+31.8%	08/04/2026
Mark Palmer StoneX	Buy	Reiterated	$195.00	+97.8%	08/05/2026
Stephen Glagola KBW	Buy	Maintained	$154.00	+56.2%	08/06/2026
Darren Aftahi Lucid Capital	Buy	Maintained	$245.00	+148.5%	08/05/2026
Nick Giles B. Riley Securities	Buy	Maintained	$163.00	+65.3%	08/03/2026
George Sutton Craig-Hallum	Buy	Maintained	-	-	07/07/2026
Jonathan Petersen Jefferies	Buy	Maintained	$156.00	+58.2%	07/06/2026
Unknown Analyst Lucid Capital	Buy	Initiated	$226.00	+129.2%	06/22/2026
Matthew Galinko Maxim Group	Buy	Reiterated	$135.00	+36.9%	05/08/2026
Gregory P Miller Citizens JMP	Buy	Maintained	$140.00	+42%	05/07/2026
Brett Knoblauch Cantor Fitzgerald	Buy	Maintained	$80.00	-18.9%	04/09/2026
Pierre-Marie d'Ornano Arete Research	Buy	Initiated	$136.00	+37.9%	03/23/2026
Kevin Dede H.C. Wainwright	Buy	Reiterated	$80.00	-18.9%	02/26/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	83.51M	88.49M	71.02M	74.93M
Cost of goods sold	32.33M	35.01M	25.55M	26.89M
Cost of revenue	32.33M	35.01M	25.55M	26.89M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	22.96M	52.33M	81.74M	76.08M
Operating expense	-25.84M	493.96M	415.84M	254.40M
Total operating expenses	6.49M	528.97M	441.39M	281.30M
Operating income	77.02M	-440.47M	-370.37M	-206.36M
Other non operating income	4.93M	54.54M	40.22M	18.24M
EBT including unusual items	69.63M	-380.00M	-302.08M	-208.60M
EBT excluding unusual items	73.99M	-385.61M	-335.68M	-209.75M
Income tax expense	19.02M	-78.22M	-48.94M	-31.46M
Effective tax rate	27.31%	20.59%	16.20%	15.08%
Other operating expenses	-76.60M	401.88M	295.66M	138.60M
Net income	50.11M	-279.68M	-219.85M	-150.19M
Net profit margin	60.00%	-316.05%	-309.57%	-200.44%
Earnings per share	-0.05	-2.12	0.10	-0.39
Interest and investment income	-	-	-	27.08M
Interest expense	-8.62M	-5.59M	-9.24M	-51.16M
Net interest expenses	-8.62M	-5.59M	-9.24M	-24.08M
Depreciation and amortization charges	27.80M	39.75M	38.44M	39.73M
EBITDA	104.81M	-400.72M	-331.93M	-166.64M
Gain or loss from assets sale	1.47M	984.00K	-33.60M	-1.14M

Ask anything